4.18
Schlusskurs vom Vortag:
$4.25
Offen:
$4.27
24-Stunden-Volumen:
317.01K
Relative Volume:
0.27
Marktkapitalisierung:
$133.19M
Einnahmen:
$160.43M
Nettoeinkommen (Verlust:
$-227.64M
KGV:
-0.0608
EPS:
-68.77
Netto-Cashflow:
$-170.79M
1W Leistung:
-7.52%
1M Leistung:
-28.91%
6M Leistung:
+46.15%
1J Leistung:
-16.23%
Agenus Inc Stock (AGEN) Company Profile
Firmenname
Agenus Inc
Sektor
Branche
Telefon
781-674-4410
Adresse
3 FORBES ROAD, LEXINGTON, MA
Vergleichen Sie AGEN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
AGEN
Agenus Inc
|
4.18 | 135.42M | 160.43M | -227.64M | -170.79M | -68.77 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2024-07-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
2024-07-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2024-07-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
2023-06-06 | Eingeleitet | Robert W. Baird | Outperform |
2023-02-28 | Fortgesetzt | H.C. Wainwright | Buy |
2022-09-28 | Eingeleitet | SMBC Nikko | Outperform |
2021-12-16 | Eingeleitet | H.C. Wainwright | Buy |
2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
2019-04-22 | Eingeleitet | B. Riley FBR | Buy |
2016-10-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
2016-10-27 | Bestätigt | Maxim Group | Buy |
2016-03-11 | Hochstufung | Maxim Group | Hold → Buy |
2015-12-16 | Eingeleitet | Jefferies | Buy |
2015-10-27 | Herabstufung | Maxim Group | Buy → Hold |
2015-07-27 | Bestätigt | MLV & Co | Buy |
2015-06-11 | Eingeleitet | Oppenheimer | Outperform |
2015-01-12 | Bestätigt | Maxim Group | Buy |
2015-01-09 | Bestätigt | MLV & Co | Buy |
2015-01-09 | Bestätigt | Maxim Group | Buy |
2014-12-19 | Bestätigt | Maxim Group | Buy |
2014-05-08 | Bestätigt | Maxim Group | Buy |
2014-03-14 | Bestätigt | MLV & Co | Buy |
2013-10-08 | Bestätigt | Maxim Group | Buy |
2012-01-05 | Eingeleitet | William Blair | Outperform |
2011-12-01 | Eingeleitet | Global Hunter Securities | Buy |
Alle ansehen
Agenus Inc Aktie (AGEN) Neueste Nachrichten
Real time scanner hits for Agenus Inc. explained2025 Geopolitical Influence & Daily Chart Pattern Signals - Newser
Comparing Agenus Inc. in custom built stock radars2025 Market Trends & High Accuracy Swing Entry Alerts - Newser
Does Agenus Inc. qualify in momentum factor screeningJuly 2025 PostEarnings & Stepwise Entry and Exit Trade Signals - Newser
Will Agenus Inc. stock recover after recent drop2025 Big Picture & Technical Confirmation Alerts - Newser
Technical signs of recovery in Agenus Inc.Fed Meeting & Weekly Momentum Picks - Newser
Detecting support and resistance levels for Agenus Inc.Earnings Summary Report & Detailed Earnings Play Alerts - Newser
Real time pattern detection on Agenus Inc. stockJuly 2025 Catalysts & Community Trade Idea Sharing Platform - Newser
Using Python tools to backtest Agenus Inc. strategiesTrade Risk Assessment & Expert Approved Momentum Trade Ideas - Newser
Can Agenus Inc. disrupt its industry getLinesFromResByArray error: size == 0 - thegnnews.com
Agenus Inc. stock trendline breakdownJuly 2025 Movers & Comprehensive Market Scan Insights - Newser
How to read the order book for Agenus Inc.2025 Volatility Report & Technical Entry and Exit Tips - Newser
Historical volatility pattern of Agenus Inc. visualizedShort Setup & Smart Swing Trading Alerts - Newser
How to build a dashboard for Agenus Inc. stockQuarterly Trade Review & Capital Efficient Trading Techniques - Newser
Shareholder Rights Advocates at Levi & Korsinsky Investigate Agenus Inc. (AGEN) Regarding Possible Securities Fraud Violations - ACCESS Newswire
BOT/BAL Advancements, BATTMAN Trial, FDA Approval Challenges and Key Highlights from Agenus Stakeholder Briefing - Oncodaily
FDA Tightens Survival Standards as Cancer Drug Pipeline Hits $866B Market Milestone - The Globe and Mail
Finanzdaten der Agenus Inc-Aktie (AGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):